Citius Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTOR and other ETFs, options, and stocks.About CTOR
Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma.
CTOR Key Statistics
Stock Snapshot
As of today, Citius Oncology(CTOR) shares are valued at $0.64. The company's market cap stands at 56.17M, with a P/E ratio of -2.09.
On 2026-03-22, Citius Oncology(CTOR) stock traded between a low of $0.62 and a high of $0.72. Shares are currently priced at $0.64, which is +4.1% above the low and -10.7% below the high.
The Citius Oncology(CTOR)'s current trading volume is 289.52K, compared to an average daily volume of 259.14K.
In the last year, Citius Oncology(CTOR) shares hit a 52-week high of $6.19 and a 52-week low of $0.59.
In the last year, Citius Oncology(CTOR) shares hit a 52-week high of $6.19 and a 52-week low of $0.59.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.